Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial
Related Experiment Video
Updated: May 20, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Samuli Rautava1, Maria Carmen Collado, Seppo Salminen
1Department of Paediatrics, Turku University Hospital, Turku, Finland. samrau@utu.fi
Insights
Prenatal microbial exposure influences fetal immune gene expression. Maternal probiotic supplementation can modulate these fetal immune responses, impacting both the placenta and the fetal gut.
Area of Science:
- Immunology
- Microbiology
- Maternal-Fetal Medicine
Background:
- Early host-microbe interactions are crucial for immune system development.
- The impact of prenatal microbial exposure on fetal immunity is not well understood.
Purpose of the Study:
- To determine if placental or amniotic fluid microbes affect fetal innate immune gene expression.
- To investigate if probiotics modulate these immune gene expression profiles.
Main Methods:
- A double-blind clinical trial involving 43 pregnant women receiving probiotics or placebo.
- Quantitative PCR (qPCR) used to detect bacteria and assess Toll-like receptor (TLR)-related gene expression in placenta and meconium.
Main Results:
- Bacterial DNA was present in all placenta samples.
- In utero microbial DNA correlated with altered TLR-related gene expression in the fetal intestine.
- Maternal probiotic intake significantly modulated TLR-related gene expression in both placenta and fetal gut.
Conclusions:
- In utero microbial contact alters fetal intestinal innate immune gene expression.
- Maternal probiotic supplementation can modulate fetal and placental immune physiology.
Background:
Early host-microbe interaction provides important maturational stimuli for the developing immune system. The role of prenatal microbial contact remains elusive.
Objectives:
Our aim was to investigate whether microbes in placenta or amniotic fluid affect fetal innate immune gene expression during late pregnancy and whether innate immune gene expression profiles in the placenta and the fetal gut may be modulated by dietary supplementation with specific probiotics.
Methods:
Altogether 43 pregnant women were randomized to receive (1) Bifidobacterium lactis, (2) B. lactis in combination with Lactobacillus rhamnosus GG (LGG) or (3) placebo for 14 days before elective cesarian section at full term in a double-blind clinical trial. Bacteria in amniotic fluid and placenta were detected by quantitative (q)PCR. The expression of Toll-like receptor (TLR)-related genes in the placenta and meconium samples was assessed by qPCR. Gene expression patterns in meconium were interpreted to reflect immune physiology in the fetal gut.
Results:
The study was completed by 29 mother-infant pairs. Bacterial DNA was detected in all placenta samples. Microbial DNA in amniotic fluid and placenta was associated with changes in TLR-related gene expression in the fetal intestine. Maternal probiotic supplementation significantly modulated the expression of TLR-related genes both in the placenta and in the fetal gut.
Conclusions:
Microbial contact in utero is associated with changes in fetal intestinal innate immune gene expression profile. Fetal and placental immune physiology may be modulated by maternal dietary intervention using specific probiotics.
Related Concept Videos
Probiotics
Introduction to the Human Microbiota
Development of Human Microbiota
Development of the Oral Microbiota
Gut-Brain Axis
Functions of the Gut Microbiota
